Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26FQ3LB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,789
Award facts
- Contract value 100% obligated
- $14,789.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $14,789.45 delivery order to Amerisourcebergen Drug Corp on July 16, 2026, for Cosentyx (secukinumab) 300 mg subcutaneous injection, 2 pen/mL formulation. Ultimate completion date is July 17, 2026.
Place of performance is Conshohocken, PA. Amerisourcebergen is a pharmaceutical distributor and medical supplier operating under its parent company Cencora, Inc., competing on full-and-open basis without set-asides. The order is firm fixed-price.
Quick answers
Who was awarded contract SPE2DR26FQ3LB?
SPE2DR26FQ3LB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 16, 2026.
How much is contract SPE2DR26FQ3LB worth?
The government has obligated $14,789 on SPE2DR26FQ3LB.
Is contract SPE2DR26FQ3LB an order under another contract?
Yes. SPE2DR26FQ3LB is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FQ3LB competed?
The extent of competition for SPE2DR26FQ3LB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award